IS110 Lipid Lowering as an Anti-inflammatory Therapy on Vulnerable Atherosclerotic Plaques
スポンサーリンク
概要
- 論文の詳細を見る
- 社団法人日本循環器学会の論文
- 2000-03-01
著者
-
Aikawa Masanori
Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School
-
Aikawa Masanori
Cardiovascular Department Brigham And Women's Hospital Harvard Medical School
-
Aikawa Masanori
Cardiovascular Division Brigham And Women's Hospital Harvard Medical School
関連論文
- OE-226 Toll-like 2 Receptor Mediates Apolipoprotein CIII-induced Monocyte Activation(OE39,Infection/Inflammation/Immunity (H),Oral Presentation (English),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
- Characterization of Vascular Smooth Muscle Progenitor Cells in Human Peripheral Blood
- 3 Characterization of Human Atherosclerotic Plaques by Intravascular Magnetic Resonance Imaging(ACC-JCS Joint Symposium "Detection and Treatment of Vulnerable Patients", The 71st Annual Scientific Meeting of the Japanese Circulation Society)
- Genetically-determined resistance to collagenase action alters content of collagen and smooth muscle cells in atheroma
- Lipid-lndependent Effects of Statins in the Clinic : Do We Know Enough?
- IS110 Lipid Lowering as an Anti-inflammatory Therapy on Vulnerable Atherosclerotic Plaques
- Expanding Role of Delta-Like 4 Mediated Notch Signaling in Cardiovascular and Metabolic Diseases